Asset Details
Do you wish to reserve the book?
Assessing quality of life in papillary thyroid cancer through a cross-sectional comparative study of SF-26 versus ThyPRO questionnaire
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Assessing quality of life in papillary thyroid cancer through a cross-sectional comparative study of SF-26 versus ThyPRO questionnaire
Do you wish to request the book?
Assessing quality of life in papillary thyroid cancer through a cross-sectional comparative study of SF-26 versus ThyPRO questionnaire
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Assessing quality of life in papillary thyroid cancer through a cross-sectional comparative study of SF-26 versus ThyPRO questionnaire
2025
Overview
Despite excellent survival rates, papillary thyroid cancer (PTC) may negatively affect patients’ quality of life (QoL), especially due to fear of recurrence. This study aims to evaluate the applicability of the Thyroid-Related Patient-Reported Outcome Questionnaire (ThyPRO) in patients with PTC and to assess its correlation with the widely used SF-36 QoL instrument. A total of 121 PTC patients who underwent total thyroidectomy between July 2019 and June 2021 at Ankara University were enrolled. Patients those with comorbidities were excluded. QoL was assessed using the ThyPRO and SF-36 questionnaires. Thyroid function tests and ultrasound findings were also collected. Moderate negative correlations were identified between several corresponding subscales of ThyPRO and SF-36: tiredness and vitality (
r
= − 0.546,
p
< 0.001); anxiety (
r
= − 0.446), depressivity (
r
= − 0.403), and emotional susceptibility (
r
= − 0.545) with mental health (all
p
< 0.001); impaired social life with social functioning (
r
= − 0.378,
p
< 0.001); and impaired daily life with role-physical and role-emotional (
r
= − 0.335,
p
< 0.001). However, no significant correlation was found between the overall QoL scores of ThyPRO and the general health domain of SF-36 (
r
= − 0.157,
p
= 0.087). ThyPRO demonstrates acceptable validity when compared with SF-36 in relevant domains and may serve as a disease-specific instrument for QoL assessment in patients with PTC.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
